R3VIVE.ME PT-141 20mg / 3ml contains Bremelanotide, a synthetic peptide studied for its interaction with melanocortin receptors and related signalling pathways.

Bremelanotide has been investigated in scientific research involving melanocortin receptor activity, cellular signalling, and physiological responses associated with the melanocortin system.

Laboratory investigations may examine:

• Melanocortin receptor signalling
• Peptide-receptor interactions
• Cellular signalling pathways
• Neuroendocrine research
• Physiological response modelling
• Peptide pharmacology studies

The 20mg / 3ml formulation provides a concentrated research preparation suitable for controlled laboratory investigation.

Key Features

• R3VIVE.ME PT-141 formulation
• 20mg / 3ml preparation
• Contains Bremelanotide
• CAS: 189691-06-3
• 99% purity as stated on the packaging
• Stabilised and pH balanced formulation
• Suitable for controlled laboratory research

How to Use (Research Reference Only)

This product is intended exclusively for laboratory and scientific research conducted by qualified professionals using appropriate research protocols.

Handling, storage, preparation, and experimental procedures should be determined according to the applicable laboratory protocol and institutional requirements.

Not intended for human consumption.

Research Applications

PT-141 / Bremelanotide is commonly investigated in research involving:

• Melanocortin receptor activity
• Peptide signalling
• Neuroendocrine pathways
• Receptor pharmacology
• Cellular signalling research
• Physiological pathway modelling

Research Disclaimer R3VIVE.ME PT-141 20mg

For laboratory and scientific research use only.

Not intended for human consumption, therapeutic use, or medical application.